Results 81 to 90 of about 1,818 (146)

Immunogenicity and safety of AS03-adjuvanted A/Astrakhan/3212/2020 (H5N8)-like influenza vaccine in adults: Phase 1/2, observer-blinded, randomized trial. [PDF]

Hum Vaccin Immunother
Hastie A, Gupta V, Lese P, Moya J, Schoonbroodt S, Beudjekian S, Struyf F.   +6 more
europepmc   +1 more source

Investigation and impact of mammalian adaptation markers on H5N8 high pathogenicity avian influenza polymerase activity. [PDF]

Npj Viruses
Fusade-Boyer M, Kocher A, Bessière P, Figueroa T, Foret-Lucas C, Vergne T, Chevalier C, Ducatez MF, Volmer R.   +8 more
europepmc   +1 more source

Concurrent circulation of avian influenza viruses H5N1 and H9N2 enhances the genetic evolution of reassortant viruses in Egyptian poultry populations. [PDF]

PLoS One
Yehia N, Ibrahim M, Shady RM, Mohamed AAE, Said D, Taha ME, Arafa A, Eid S, Shalaby MA, Truyen U, Kobialka RM, Abd El Wahed A, Ceruti A.   +12 more
europepmc   +1 more source

Molecular surveillance and predictive risk modelling of avian influenza virus in wild birds in Egypt. [PDF]

J Gen Virol
Nabil NM, Tawakol MM, Hagag N, Eid S, Brierley L, Naguib MM.   +5 more
europepmc   +1 more source

Avian influenza in Ireland: a spatiotemporal, subtype and host-based analysis (1983-2024). [PDF]

J Gen Virol
Farrell ML, McGrath G, Cuartero LG, Barry G.   +3 more
europepmc   +1 more source

MF59-adjuvanted A/Astrakhan influenza vaccine induces cross-neutralizing H5N1 antibodies in ferrets against circulating clade 2.3.4.4b viruses. [PDF]

NPJ Vaccines
Segovia K, Rathnasinghe R, Patton C, Kwon B, Longstaff RA, Hofmann D, Banger KK, Xu H, Lacey M, Settembre E, Palladino G, Kennedy AT, Music N.   +12 more
europepmc   +1 more source

Genomic and evolutionary characterization of newly emerged highly pathogenic avian influenza H5N1 clade (2023-2025). [PDF]

Vet World
Shosha EAE, Mohamd MK, Shehata MAE, Mohamed MH, Eldaghayes IM, Abdelhafez MS.   +5 more
europepmc   +1 more source

Serologic Surveillance of Highly Pathogenic Avian Influenza Virus Subtype H5 in Wildlife, Northeast Germany, 2023-2025. [PDF]

Emerg Infect Dis
Günther A, Wassermann J, Heck J, Bussi M, Aebischer A, Staubach C, Bergmann H, Leendertz FH, Beer M, Schares G, Wernike K.   +10 more
europepmc   +1 more source

Receptor-binding specificity and antigenic properties of a genotype D1.1 A(H5N1) influenza virus isolated from a human. [PDF]

Emerg Microbes Infect
Kandeil A, Chopra P, Ray SD, Ghotekar BK, Ranadheera C, Jeevan T, Fabrizio T, Rubrum A, Boons GJ, Tompkins SM, Bastien N, Webby RJ.   +11 more
europepmc   +1 more source

The Road to Readiness: Commentary on the Journey of a Zoonotic H5 Influenza Vaccine Strain Update. [PDF]

Vaccines (Basel)
Kennedy AT, Longstaff R, Fitzpatrick J, Hughes C, Malatesta MT, Brandi R, Beighton J, Versage E, Music N, Xu H, Pagni M, Hohenboken M, Taylor B.   +12 more
europepmc   +1 more source